Medical Properties Trust (NYSE:MPW) Upgraded to “Buy” by Colliers Securities

Medical Properties Trust (NYSE:MPW) was upgraded by equities researchers at Colliers Securities from a “neutral” rating to a “buy” rating in a research report issued on Friday, MarketBeat.com reports. The brokerage currently has a $6.50 target price on the real estate investment trust’s stock. Colliers Securities’ price objective indicates a potential upside of 2.04% from the company’s current price.

Several other brokerages have also issued reports on MPW. StockNews.com lowered shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Saturday, May 18th. Truist Financial upped their price target on shares of Medical Properties Trust from $4.50 to $5.00 and gave the company a “hold” rating in a research report on Thursday, May 30th. Finally, BNP Paribas lowered shares of Medical Properties Trust from an “outperform” rating to a “neutral” rating and cut their price target for the company from $6.00 to $4.00 in a research report on Tuesday, July 2nd. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $5.22.

Medical Properties Trust Stock Up 13.8 %

Shares of NYSE:MPW opened at $6.37 on Friday. Medical Properties Trust has a 52-week low of $2.92 and a 52-week high of $6.64. The firm has a fifty day moving average of $4.76 and a 200 day moving average of $4.68. The firm has a market capitalization of $3.82 billion, a PE ratio of -2.87, a price-to-earnings-growth ratio of 0.68 and a beta of 1.28. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.93 and a current ratio of 2.93.

Medical Properties Trust (NYSE:MPW) last announced its earnings results on Thursday, August 8th. The real estate investment trust reported ($0.54) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.75). The company had revenue of $266.60 million for the quarter, compared to the consensus estimate of $259.53 million. During the same period in the previous year, the business earned $0.48 EPS. The business’s quarterly revenue was down 21.0% compared to the same quarter last year. As a group, research analysts anticipate that Medical Properties Trust will post 0.89 EPS for the current fiscal year.

Insider Transactions at Medical Properties Trust

In related news, Director C Reynolds Thompson III sold 20,530 shares of the stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $4.38, for a total value of $89,921.40. Following the completion of the transaction, the director now directly owns 54,637 shares of the company’s stock, valued at $239,310.06. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, Director Elizabeth N. Pitman sold 10,025 shares of the stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $4.98, for a total value of $49,924.50. Following the completion of the transaction, the director now directly owns 68,653 shares of the company’s stock, valued at $341,891.94. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director C Reynolds Thompson III sold 20,530 shares of the stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total transaction of $89,921.40. Following the completion of the transaction, the director now directly owns 54,637 shares of the company’s stock, valued at $239,310.06. The disclosure for this sale can be found here. 1.53% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Medical Properties Trust

Institutional investors have recently bought and sold shares of the stock. Lindbrook Capital LLC increased its stake in shares of Medical Properties Trust by 112.1% during the first quarter. Lindbrook Capital LLC now owns 7,225 shares of the real estate investment trust’s stock valued at $34,000 after purchasing an additional 3,819 shares in the last quarter. Versant Capital Management Inc increased its stake in shares of Medical Properties Trust by 435.0% during the second quarter. Versant Capital Management Inc now owns 7,972 shares of the real estate investment trust’s stock valued at $34,000 after purchasing an additional 6,482 shares in the last quarter. Future Financial Wealth Managment LLC bought a new position in shares of Medical Properties Trust during the first quarter valued at approximately $38,000. Iron Horse Wealth Management LLC increased its stake in shares of Medical Properties Trust by 166.7% during the second quarter. Iron Horse Wealth Management LLC now owns 8,000 shares of the real estate investment trust’s stock valued at $34,000 after purchasing an additional 5,000 shares in the last quarter. Finally, Fidelis Capital Partners LLC bought a new position in shares of Medical Properties Trust during the first quarter valued at approximately $43,000. 71.79% of the stock is owned by institutional investors.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.